All Stories

  1. Co-design of a trustworthy AI-based prognostic tool for predicting patient outcome in acute stroke
  2. Hiding in plain sight: A call to prevent cutaneous leishmaniasis transmission in the United States
  3. Beyond Detection: Comparative Explainability Study on Trypanosoma cruzi Using CAMs and DETR Attention
  4. Assessing ventilation through ambient carbon dioxide concentrations across multiple healthcare levels in Ghana
  5. The impact of anthropogenic climate change on pediatric viral diseases
  6. Lessons Learned from Assessing Trustworthy AI in Practice
  7. Vitasd: Robust Vision Transformer Baselines for Autism Spectrum Disorder Facial Diagnosis
  8. Assessing Trustworthy AI in Times of COVID-19: Deep Learning for Predicting a Multiregional Score Conveying the Degree of Lung Compromise in COVID-19 Patients
  9. Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms
  10. To explain or not to explain?—Artificial intelligence explainability in clinical decision support systems
  11. Improving Tuberculosis (TB) Prediction using Synthetically Generated Computed Tomography (CT) Images
  12. Co-Design of a Trustworthy AI System in Healthcare: Deep Learning Based Skin Lesion Classifier
  13. On Assessing Trustworthy AI in Healthcare. Machine Learning as a Supportive Tool to Recognize Cardiac Arrest in Emergency Calls
  14. COVID-19 early-alert signals using human behavior alternative data
  15. Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)
  16. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
  17. Déjà vu: Stimulating open drug discovery for SARS-CoV-2
  18. Towards an Artificial Intelligence Framework for Data-Driven Prediction of Coronavirus Clinical Severity
  19. Case Report: A Cluster of Three Leptospirosis Cases in a New York City Abattoir and an Unusual Complication in the Index Case
  20. Use of a community-led prevention strategy to enhance behavioral changes towards Ebola virus disease prevention: a qualitative case study in Western Côte d’Ivoire
  21. Illustrating and homology modeling the proteins of the Zika virus
  22. Modeling the proteins in the Zika virus
  23. Can Open Drug Discovery efforts contribute to a cure for the Zika Virus?
  24. Prognostic Indicators for Ebola Patient Survival
  25. Addressing the next viral outbreak
  26. Repurposing Approved drugs for Ebola
  27. How do we fight the next pathogen we discover?
  28. drugs for Ebola
  29. pharmacophore for compounds active against Ebola
  30. pharmacophore for compounds active against Ebola
  31. Effect of the One-Child Policy on Influenza Transmission in China: A Stochastic Transmission Model
  32. HIV andSchistosoma haematobiumprevalences correlate in sub-Saharan Africa
  33. Modelling the impact of migration on the HIV epidemic in South Africa
  34. Dynamically Modeling SARS and Other Newly Emerging Respiratory Illnesses
  35. Patterns of Movement and Risk of HIV Infection in Rural Zimbabwe
  36. In Vivo Radioprotective Effects of Angiogenic Growth Factors on the Small Bowel of C3H Mice
  37. Pharmacophores, receptor ligand models and docking data<b> </b>for FDA-approved drugs inhibiting the Ebola virus